From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery
The patient group | Test U | P value | |||
---|---|---|---|---|---|
Carotid atherosclerosis N = 50 | Cardioembolic N = 50 | Total N = 100 | |||
Number of plaques | |||||
X ± SD | 7.16 ± 5.23 | 0.0 ± 0.0 | 3.58 ± 5.15 | 8.4 | < 0.001 |
Range | 0–17 | 0–0 | 0–17 |
No | % | No | % | X2 | ||||
---|---|---|---|---|---|---|---|---|
Plaque burden | ||||||||
No plaques | 6 | 12.0 | 50 | 100 | 56 | 56 | 78.6 | < 0.001 |
Mild | 14 | 28.0 | 0 | 0 | 14 | 14 | ||
Moderate | 10 | 20.0 | 0 | 0 | 10 | 10 | ||
Severe | 20 | 40.0 | 0 | 0 | 20 | 20 |